Enhanced bacoside content in polyamine treated in-vitro raised Bacopa monnieri (L.) Wettst
-
Add time:08/21/2019 Source:sciencedirect.com
The study was designed to evaluate the role of various plant polyamines (PAs) on in-vitro multiplication and regeneration in the Ayurvedic memory enhancer Bacopa monnieri (L.) Wettst. Natural populations of B. monnieri were collected, sterilized and micropropagated in Murashige and Skoog (MS) media supplemented with different concentration and combination of plant growth regulators (PGRs) and PAs. MS media supplemented with 6-benzylaminopurine (BAP) (2.0 mg/l) + spermidine (spd) (1 mM) and in another set, kinetin (kin) (2.0 mg/l) + spd (1 mM) were found to be the best multiplication media whereas MS + indole-3-butyric acid (IBA) (1.0 mg/l) + spermine (spm) (1.0 mM) produced highest average number of roots per shoot. After 4–6 weeks of incubation, nodal explants cultured in MS media supplemented with various PGRs and PAs produced green compact or white friable nodular base calli (NBC). The NBC showed organogenic potential when subjected to MS media supplemented with cytokinins and PAs. Clonal fidelity of the regenerated plants was assessed using inter-simple sequence repeat (ISSR) and random-amplified polymorphic DNA (RAPD) markers. Out of the 60 clear and reproducible bands recorded, 54 were found to be monomorphic displaying high degree of monomorphism (90%) and lower polymorphic level (10%) between the mother plant and in-vitro regenerants. High-performance liquid chromatography (HPLC) revealed total bacoside content in B. monnieri grown in-vitro (PA-treated) and the mother plant (MP) grown in nature to be 27.89 and 25.46 mg/g respectively. The phytochemical analysis of the PA-treated micropropagated plants also revealed significantly higher levels of phenolics and flavonoids with comprehensively higher antioxidant potentials in PA-treated in-vitro grown plants (PATP) and the subsequently acclimatized plants (PATP-A) over the PA-untreated in-vitro grown plants (with/no PGR) (PAUP) and the mother plant (MP).
We also recommend Trading Suppliers and Manufacturers of BACOSIDE A (cas 11028-00-5). Pls Click Website Link as below: cas 11028-00-5 suppliers
Prev:Elite genotypes of Bacopa monnieri, with high contents of BACOSIDE A (cas 11028-00-5) and Bacopaside I, from southern Western Ghats in India
Next:Surface modified PLGA nanoparticles for brain targeting of Bacoside-A) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research articleZinc oxide nanoparticles (ZnO NP) mediated regulation of bacosides biosynthesis and transcriptional correlation of HMG-CoA reductase gene in suspension culture of Bacopa monnieri08/25/2019
- Production of BACOSIDE A (cas 11028-00-5), a memory enhancer from hairy root cultures of Bacopa monnieri (L.) Wettst08/24/2019
- Bacoside-A, an anti-amyloid natural substance, inhibits membrane disruption by the amyloidogenic determinant of prion protein through accelerating fibril formation08/23/2019
- Surface modified PLGA nanoparticles for brain targeting of Bacoside-A08/22/2019
- Elite genotypes of Bacopa monnieri, with high contents of BACOSIDE A (cas 11028-00-5) and Bacopaside I, from southern Western Ghats in India08/20/2019
- BACOSIDE A (cas 11028-00-5) and bromelain relieve dichlorvos induced changes in oxidative responses in mice serum08/19/2019
- Protective propensity of BACOSIDE A (cas 11028-00-5) and bromelain on renal cholinesterases, γ-Aminobutyric acid and serotonin level of Mus musculus intoxicated with dichlorvos08/18/2019
- Attenuation of cytotoxicity induced by tBHP in H9C2 cells by Bacopa monniera and BACOSIDE A (cas 11028-00-5)08/17/2019
- Bacoside-A inhibits inflammatory cytokines and chemokine in experimental autoimmune encephalomyelitis08/16/2019


